Krilogy Financial’s Assembly Biosciences ASMB Stock Holding History

Krilogy Financial’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-8	Closed	-$4K	–	175
2018 Q3	$4K	Buy	+8	New	+$3.75K	﹤0.01%	640

Other funds holding ASMB

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Krilogy Financial's ASMB Position: Q4 2018 in Review

Krilogy Financial sold out of Assembly Biosciences (ASMB) in Q4 2018, closing a stake of 8 shares — an estimated $4K sold.

Krilogy Financial first reported a position in ASMB in Q3 2018 and held it in 1 quarter. The position peaked at $4K in Q3 2018. 106 funds tracked by Wall St. Rank hold ASMB as of Q4 2018.

Krilogy Financial reported no remaining Assembly Biosciences position as of Q4 2018 after selling out during the quarter.
Krilogy Financial sold 8 Assembly Biosciences shares in Q4 2018, an estimated $4K.
Krilogy Financial first reported a position in Assembly Biosciences in Q3 2018 and held it in 1 quarter.
Krilogy Financial's Assembly Biosciences position peaked at $4K in Q3 2018.
106 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2018.

Based on Krilogy Financial's 13F filing for Q4 2018, filed 14 Feb 2019.